The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more and more ...

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Shares of Novo Nordisk have dropped as the company's largest investor, Novo Nordisk Foundation, calls for a board overhaul. The foundation plans to appoint Lars Rebien Sorensen as chair, following a ...

The Novo Foundation chair said the current board of the Wegovy maker, which is already dealing with layoffs and a CEO change, was too slow to react to obesity market shifts.

The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...

Novo Nordisk is facing a rare governance earthquake after Chairman Helge Lund resigned following a clash with the company's biggest share ...

But Doustdar also seems to recognize what he has in Novo Nordisk, the 100-year-old pharma that brought insulin to the masses, ...

The Novo Nordisk Foundation, which controls the firm, wanted faster action and a more significant reshuffle of the board, ...

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

Novo Nordisk to reshuffle its board after a clash with its largest shareholder over governance changes. Read more here.

Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...

Novo Holdings, which controls obesity drugmaker Novo Nordisk , is sharpening its focus on India, targeting single-specialty ...